On May 3, 2023, Gov. Moore signed HB 1217/SB 805 into law. The law requires health insurers in Maryland to cover biomarker testing when supported by medical and scientific evidence. Cost-sharing for biomarker testing may not be greater than cost-sharing for similar covered services. As of January 1, 2024, the law applies to policies issued or delivered in the state. Employers sponsoring health plans in Maryland should be aware of this development and contact their carriers for further information.
HB 1217 »
PPI Benefit Solutions does not provide legal or tax advice. Compliance, regulatory and related content is for general informational purposes and is not guaranteed to be accurate or complete. You should consult an attorney or tax professional regarding the application or potential implications of laws, regulations or policies to your specific circumstances.
Subscribe